Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Barry currently holds 2,983,542 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Barry has been a net seller of SRPT stock. They have purchased $11.3M and sold $19.1M worth of shares.
Richard Barry's most recent insider trade was on Jun 4, 2026, when they sold 16,875 shares at $0.00 per share.
Richard Barry serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 46 insider transactions totaling $30.4M over their tenure at the company.
Richard Barry holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Richard Barry has shown a selling trading pattern, with $11.3M in total purchases and $19.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard Barry was on Jun 27, 2018, when they sold $9.8M worth of SRPT shares. This transaction involved 75,000 shares at $130.34 per share.
Richard Barry currently owns 2,983,542 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Barry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Barry has 46 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Richard Barry and 40,000+ other insiders.